secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lite Strategy, Inc. (LITS)
CIK:        0001262104
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0001193125-23-159435
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MEI Pharma names David Urso CEO, succeeds Daniel Gold in planned transition
---------------------------------------------------------------------------

- David Urso appointed President and CEO effective June 2, 2023; Daniel Gold terminated without cause.
- Gold receives 12 months base salary severance, accelerated vesting of stock options, and stays on board.
- Urso gets base salary $614K, 50% target bonus, and initial option grant for 2.5% of outstanding shares.
- Additional option grant for up to 2.5% of shares contingent on closing of pending Infinity merger.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1262104/000119312523159435/0001193125-23-159435-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1262104/000119312523159435/d484383d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-159435

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer